Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma von Gardner, Heather L, Rippy, Sarah B, Bear, Misty D, Cronin, Kim L, Heeb, Heather, Burr, Holly, Cannon, Claire M, Penmetsa, Kumar V, Viswanadha, Srikant, Vakkalanka, Swaroop, London, Cheryl A

Volltext

The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation[S] von Wojtanik, Kari M., Edgemon, Keith, Viswanadha, Srikant, Lindsey, Brigette, Haluzik, Martin, Chen, Weiping, Poy, George, Reitman, Marc, Londos, Constantine

Volltext

Optimized conditions for measuring lipolysis in murine primary adipocytes von Viswanadha, Srikant, Londos, Constantine

Volltext

A Novel, Potent, Small Molecule AKT Inhibitor Exhibits Efficacy against Lung Cancer Cells In Vitro von Dinavahi, Saketh S, Prasanna, Rajagopalan, Dharmarajan, Sriram, Perumal, Yogeeswari, Viswanadha, Srikant

Volltext

Pre-Clinical Efficacy of RP6503 in PI3Kδ/γ Mediated Airway Disorders von Vakkalanka, Swaroop, PhD, Govandarajulu, Babu, PhD, Routhu, Kasiviswanath, PhD, Veeraraghavan, Sridhar, M.Pharm, Viswanadha, Srikant, PhD, Nagarathnam, Dhanapalan, PhD

Volltext

Abstract C042: Inhibition of Dihydroorotate Dehydrogenase (DHODH) by RP7214 attenuates growth and promotes differentiation of AML cell lines von Viswanadha, Srikant, Eleswarapu, Satyanarayana, Vakkalanka, Swaroop

Volltext

Hepatic Metabolic, Inflammatory, and Stress-Related Gene Expression in Growing Mice Consuming a Low Dose of Trans-10, cis -12-Conjugated Linoleic Acid von Li, Jing, Viswanadha, Srikant, Loor, Juan J.

Volltext

Abstract B128: Efficacy of RP4010, a calcium release-activated calcium (CRAC) inhibitor, in preclinical models of DLBCL von Viswanadha, Srikant, Eleswarapu, Satyanarayana, Vakkalanka, Swaroop

Volltext

Abstract C044: RP7214, a small molecule inhibitor of dihydroorotate dehydrogenase (DHODH), potentiates activity of Gilteritinib and Cytarabine in preclinical models of AML von Viswanadha, Srikant, Eleswarapu, Satyanarayana, Penmetsa, Kumar V., Vakkalanka, Swaroop

Volltext

Abstract C045: RP4010, a small molecule inhibitor of Store-Operated Calcium Entry (SOCE), potentiates activity of Gilteritinib and Cytarabine in preclinical models of AML von Viswanadha, Srikant, Eleswarapu, Satyanarayana, Penmetsa, Kumar V., Vakkalanka, Swaroop

Volltext

Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530 von Locatelli, Silvia L, Careddu, Giuseppa, Serio, Simone, Consonni, Francesca M, Maeda, Akihiro, Viswanadha, Srikant, Vakkalanka, Swaroop, Castagna, Luca, Santoro, Armando, Allavena, Paola, Sica, Antonio, Carlo-Stella, Carmelo

Volltext

Abstract 1233: Preclinical profile of RP12146, a novel, selective, and potent small molecule inhibitor of PARP1/2 von Viswanadha, Srikant, Eleswarapu, Satyanarayana, Rasamsetti, Kondababu, Bhuniya, Debnath, Merikapudi, Gayatriswaroop, Veeraraghavan, Sridhar, Vakkalanka, Swaroop

Volltext

Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC–MS/MS: Application to a pharmacokinetic study von Veeraraghavan, Sridhar, Viswanadha, Srikant, Thappali, Satheeshmanikandan, Govindarajulu, Babu, Vakkalanka, Swaroopkumar, Rangasamy, Manivannan

Volltext

Abstract 5492: Activity of RP7214, a novel, selective, and potent small molecule inhibitor of DHODH, in AML von Viswanadha, Srikant, Eleswarapu, Satyanarayana, Vakkalanka, Swaroop

Volltext

Abstract 4875: Addition of RP10107, a novel and potent glutaminase inhibitor, accentuates 5-FU activity in lung cancer cell lines in vitro von Viswanadha, Srikant, Eleswarapu, Satyanarayana, Nyayapathy, Seeta, Vakkalanka, Swaroop

Volltext

Abstract 1889: Synergistic effects of glutaminase and proteasome inhibition in multiple myeloma cell lines von Viswanadha, Srikant, Eleswarapu, Satyanarayana, Penmetsa, Kumar V., Vakkalanka, Swaroop

Volltext

Pharmacodynamic evaluation of RP3128, a novel and potent CRAC channel inhibitor in guinea pig models of allergic asthma von Sutovska, Martina, Kocmalova, Michaela, Franova, Sona, Vakkalanka, Swaroop, Viswanadha, Srikant

Volltext

Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders von Routhu, Kasi Viswanath, Veeraraghavan, Sridhar, Merikapudi, Gayatri Swaroop, G, Babu, Viswanadha, Srikant, Vakkalanka, Swaroop

Volltext

Abstract 2704: RP6530, a dual PI3K δ/γ inhibitor, potentiates ruxolitinib activity in the JAK2-V617F mutant erythroleukemia cell lines von Vakkalanka, Swaroop, Nyayapathy, Seeta, Viswanadha, Srikant

Volltext

A first‐in‐human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release‐activated calcium (CRAC) channel modulator in healthy volunteers... von Barde, Prajak J., Viswanadha, Srikant, Veeraraghavan, Sridhar, Vakkalanka, Swaroop V., Nair, Ajit

Volltext